Executives On The Move: Changes At Compass Therapeutics, Homology Medicines and More
Executive Summary
Recent executive changes in the industry include C-suite changes at Homology Medicines and SelectImmune Pharma. Meanwhile, new directors were appointed at Galapagos and Compass Therapeutics.
You may also be interested in...
Executives On The Move: Changes At Alligator Bioscience, Legend Biotech and More
Recent executive changes in the industry include C-suite changes at Legend Biotech and Seagen. Meanwhile, new directors were appointed at Alligator Bioscience and Kintor Pharmaceutical, among others.
Pipeline Watch: Two Approvals And Four Phase III Trial Starts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: 16 Approvals And Six Phase III Trial Starts
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.